CDXC - ChromaDex Corporation (CDXC) Q1 2024 Earnings Call Transcript
2024-05-08 20:26:10 ET
ChromaDex Corporation (CDXC)
Q1 2024 Results Conference Call
May 08, 2024 04:30 PM ET
Company Participants
Ben Shamsian - IR
Rob Fried - CEO
Brianna Gerber - CFO
Andrew Shao - SVP, Scientific and Regulatory Affairs
Conference Call Participants
Ram Selvaraju - H.C. Wainwright
Mitch Pinheiro - Sturdivant & Co.
Sean McGowan - ROTH Capital Partners
Bill Dezellem - Tieton Capital
JP Mark - Farmhouse Equity Research
Presentation
Operator
Ladies and gentlemen, thank you for standing by. And welcome to ChromaDex Corporation's First Quarter of 2024 Earnings Conference Call. My name is Jericho and I will be the conference operator today. At this time, all participants are in listen-only mode. And as a reminder, this conference call is being recorded. This afternoon, ChromaDex issued a news release announcing the company's financial results for the first quarter of 2024. If you have not reviewed this information, both are available within the Investor Relations section of ChromaDex's Web site at www.ChromaDex.com. I would now like to turn the conference call over to Ben Shamsian, Vice President of Lytham Partners. Please go ahead, Mr. Shamsian.
Ben Shamsian
Thank you. Good afternoon. And welcome to ChromaDex Corporation's first quarter of 2024 results investor call. With us today are ChromaDex's Chief Executive Officer, Rob Fried; Chief Financial Officer, Brianna Gerber; and Senior Vice President of Scientific and Regulatory Affairs, Dr. Andrew Shao, who will join the call for Q&A. Today's conference call may include forward-looking statements, including statements related to ChromaDex's research and development and clinical trial plans and the timing and results of such trials, the timing of future regulatory filings, the expansion of the sale of Tru Niagen in new markets, business development opportunities, future financial results, cash needs, operating performance, investor interest, and business prospects and opportunities, as well as anticipated results of operations. Forward-looking statements represent only the company's estimates on the date of this conference call and are not intended to give any assurance as to actual future results. Because forward-looking statements relate to matters that have not yet occurred, these statements are inherently subject to risks and uncertainties. Many factors could cause ChromaDex’s actual activities or results to differ materially from the activities and results anticipated in forward-looking statements. These risk factors include those contained in ChromaDex’s quarterly reports on Form 10-Q most recently filed with the SEC, including results of operations, financial condition, cash flows, as well as global market and economic conditions on our business.
Please note that the company assumes no obligation to update any forward-looking statements after the date of this conference call to conform with forward-looking statements, actual results or changes to its expectations. In addition, certain of the financial information presented in this call references non-GAAP financial measures. The company's earnings presentation and earnings press release, which were issued this afternoon and are available on the company's Web site, presents reconciliations to the appropriate GAAP measures. Finally, this conference call is being recorded via webcast. The webcast will be available at the Investor Relations section of our Web site at www.ChromaDex.com. With that, it’s now my pleasure to turn the call over to our Chief Executive Officer, Rob Fried....
ChromaDex Corporation (CDXC) Q1 2024 Earnings Call Transcript